Bcl-xL Cancer Research Results
Bcl-xL, Bcl-xL: Click to Expand ⟱
| Source: |
| Type: pro-survival proteins |
The proteins of BCL-2 family are classified into three subgroups, i.e., the anti-apoptotic/pro-survival proteins represented by BCL-2 and BCL-XL.
BCL-XL overexpressing cells exhibited higher tumors sphere formation capacity and expressed higher levels of some stem cell markers, supporting the concept that BCL-XL plays essential roles in the maintenance of cancer stem cell phenotype.
|
GC, Gastric Adenocarcinoma: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
vitro+vivo, |
GC, |
HGC27 |
|
|
|
- |
in-vitro, |
GC, |
AGS |
|
|
|
- |
in-vitro, |
GC, |
BGC-823 |
|
|
|
- |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
- |
in-vitro, |
Nor, |
HEK293 |
|
|
|
TumCP↓, TumCCA↑, Casp↑, Apoptosis↑, TrxR1↓, ROS↑, eff↓, eff↑, PI3K↓, Akt↓, TumCG↓, cl‑PARP↑, cl‑Casp3↑, cl‑Casp9↑, cl‑Casp8↑, Bcl-2↓, Bcl-xL↓, Mcl-1↓, XIAP↓, survivin↓, TumVol↓, TumW↓, Weight∅, toxicity↓, Ki-67↓, other↝,
| - |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
- |
in-vitro, |
GC, |
BGC-823 |
|
|
|
TumCP↓, Apoptosis↑, TumAuto↑, P53↑, PI3K↓, P21↑, p‑Akt↓, p‑mTOR↓, Bcl-2↓, Bcl-xL↓, LC3I↓, BAX↑, Beclin-1↑, cl‑Casp3↑, cl‑PARP↑, LC3II↑, ATG3↑, ATG5↑,
| - |
in-vitro, |
GC, |
NA |
|
|
|
- |
in-vivo, |
NA, |
NA |
|
|
|
p‑STAT3↓, STAT3↓, Mcl-1↓, survivin↓, Bcl-xL↓, HSP90↓,
| - |
in-vitro, |
GC, |
SNU16 |
|
|
|
- |
in-vitro, |
Nor, |
GES-1 |
|
|
|
TumCP↓, Apoptosis↑, BAX↑, BAD↑, Cyt‑c↑, cl‑PARP↑, cl‑Casp3↑, Bcl-2↓, Bcl-xL↓, p‑PI3K↓, p‑Akt↓, Ki-67↓, toxicity↓, RadioS↑,
| - |
in-vitro, |
GC, |
SGC-7901 |
|
|
|
- |
in-vitro, |
GC, |
NA |
|
|
|
TrxR1↓, ROS↑, ER Stress↑, mtDam↑, selectivity↑, NO↑, TumCCA↑, mt-ROS↑, Casp9↑, Bcl-2↓, Bcl-xL↓, cl‑PARP↑, eff↓, lipid-P↑,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
lipid-P↑, 1, ROS↑, 2, mt-ROS↑, 1, TrxR1↓, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
mtDam↑, 1, XIAP↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 1, p‑Akt↓, 2, Apoptosis↑, 3, BAD↑, 1, BAX↑, 2, Bcl-2↓, 4, Bcl-xL↓, 5, Casp↑, 1, cl‑Casp3↑, 3, cl‑Casp8↑, 1, Casp9↑, 1, cl‑Casp9↑, 1, Cyt‑c↑, 1, Mcl-1↓, 2, survivin↓, 2,
Transcription & Epigenetics(tgid=7) ⓘ
other↝, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
ER Stress↑, 1, HSP90↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
ATG3↑, 1, ATG5↑, 1, Beclin-1↑, 1, LC3I↓, 1, LC3II↑, 1, TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1, cl‑PARP↑, 4,
Cell Cycle & Senescence(tgid=11) ⓘ
P21↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
p‑mTOR↓, 1, PI3K↓, 2, p‑PI3K↓, 1, STAT3↓, 1, p‑STAT3↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
Ki-67↓, 2, TumCP↓, 3,
Angiogenesis & Vasculature(tgid=14) ⓘ
NO↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↓, 2, eff↑, 1, RadioS↑, 1, selectivity↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
Ki-67↓, 2,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 2, TumVol↓, 1, TumW↓, 1, Weight∅, 1,
Total Targets: 52
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: Bcl-xL, Bcl-xL
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:28 Cells:% prod#:% Target#:28 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page